1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic MigraineChronic Migraine in ChildrenRecruitingPhase 32026-08-21NCT04965675